Pernix Therapeutics, Inc. Agrees To Divest Manufacturing Facility

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HOUSTON--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ MKT:PTX), a specialty pharmaceutical company, today announced that it has signed a definitive agreement to divest its Houston, TX-based manufacturing operations, Pernix Manufacturing, LLC (“PML”) to Woodfield Pharmaceutical LLC (“Woodfield”).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC